GSEC/TYMSOS inhibited miR-101-3P to increase KIF14 expression in lung adenocarcinoma to promote immune checkpoint-related gene expression, immune cell biomarkers, and tumor immune cell infiltration [132]. The gene discussed is KIF14; the disease is lung adenocarcinoma.